Gut microbiome ecosystem (Clostridioides difficile colonization resistance)

The gut microbiome ecosystem provides colonization resistance against Clostridioides difficile through a complex network of microbial interactions and metabolic processes. In a healthy state, commensal bacteria compete for limited nutrients and produce metabolites, such as short-chain fatty acids and secondary bile acids, that inhibit the germination and vegetative growth of C. difficile (Buffie et al., 2015; Theriot et al., 2016). Disruption of this ecosystem, typically by broad-spectrum antibiotics, creates a niche that allows C. difficile to proliferate and release toxins, leading to severe diarrhea and colitis (Seekatz & Young, 2014). Therapeutic strategies targeting this ecosystem aim to restore microbial diversity and functional pathways rather than targeting a single receptor. Modern interventions include fecal microbiota transplantation (FMT) and defined live biotherapeutic products (LBPs) like Vowst and Rebyota, which have been FDA-approved to prevent recurrent C. difficile infection (Feuerstadt et al., 2022; Khanna et al., 2022). These therapies work by re-establishing the ecological balance required to suppress pathogen expansion and restore intestinal homeostasis.

Other names

Colonization resistanceCommensal gut microbiotaIntestinal microbiomeMicrobiota-mediated pathogen exclusionGut flora

Restoration of microbial diversity to provide competitive exclusion of Clostridioides difficile, restoration of secondary bile acid metabolism to inhibit spore germination, and production of short-chain fatty acids to maintain epithelial barrier integrity.